-
In order to break the monopoly of multinational pharmaceutical companies in the GLP-1 field, domestic pharmaceutical companies are making efforts
Time of Update: 2022-10-31
In July, Huadong Pharmaceutical announced that its marketing authorization application for liraglutide injection for obesity or overweight indications has been accepted by the State Food and Drug Administration.
-
The API industry has ushered in a period of opportunity, and pharmaceutical companies have accelerated their layout
Time of Update: 2022-10-31
On October 27, Zhongsheng Pharmaceutical issued an announcement that the API brofenac sodium of Xianqiang Pharmaceutical, a wholly-owned subsidiary, was approved for marketing by the State Food and Drug Administration.
-
During the disclosure period of the third quarterly report, the performance of the two major sectors of the pharmaceutical industry was eye-catching
Time of Update: 2022-10-31
As of October 26, Wind data shows that a total of 141 A-share biopharmaceutical companies have disclosed three quarterly reports, of which 84 companies have achieved a year-on-year increase in net profit attributable to the parent in the first three quarters, accounting for 59.
-
Quercus Pinnacle Bio supplies 1% 98% white potato extract industry dynamics
Time of Update: 2022-10-31
【Part of use】:Root of Ulgaris [Ingredients]: Euranthrin, isolutein, Baizhi polysaccharide 【Plant Distribution】:Nationwide 【Product Specifications】:Luteanocarbin 1% 50% 98% 【Detection Method】:HPLC 【 Product appearance]: brown yellow to off-white [product status]: fine powder [storage method]: sealed in a cool, dry place [packing]: aluminum foil bag 1kg/bag, 25kg/barrel or according to customer requirements [shelf life]: 24 months Quercus Ping Bio supplies Lutein 1% 98% White Pycnogenol Extract Industry News 1.
-
Reply to the proposal on further strengthening the construction of the traceability system for traditional Chinese medicines
Time of Update: 2022-10-31
Member Wang Rui: After receiving the "Proposal on Further Strengthening the Construction of the Traceability System for Traditional Chinese Medicine" put forward, our bureau, together with the Minist
-
The latest: 8 provinces and cities have clarified the implementation time of the seventh batch of national collective procurement
Time of Update: 2022-10-31
pharmacies The agreed procurement volume and procurement cycle of the seventh batch of selected products in the first year shall be determined in accordance with the relevant rules in the National Centralized Drug Procurement Document (GY-YD2022-1) issued by the National Joint Procurement Office.
-
Johnson & Johnson 2022Q3: blockbuster products face patent cliff, ibrutinib is "besieged"
Time of Update: 2022-10-31
Sales of ustekinumab, a blockbuster product in the field of self-exemption, exceeded $2 billion, but the patent cliff is coming In the third quarter, Johnson & Johnson's self-immunity revenue was $4.
-
Pharmacopoeia Commission: More than 300 varieties [identification] items involve deletion!
Time of Update: 2022-10-31
Source: Pharmacopoeia Commission: wangxinglai2004 On October 27, 2022, the State Pharmacopoeia Commission issued the Notice on the Announcement of the Draft Revision of the National Standard for the
-
National Health Commission Issued Guidelines for the Diagnosis and Treatment of Stomatology-related Diseases (2022 Edition)
Time of Update: 2022-10-31
General Office of the National Health Commission September 30, 2022 Health Commissions of all provinces, autonomous regions, municipalities directly under the Central Government and the Xinjiang Production and Construction Corps: In order to further improve the standardization level of oral diagnosis and treatment, ensure medical quality and safety, and safeguard the health rights and interests of patients, our commission commissioned the formulation and revision of guidelines for the diagnosis and treatment of oral related diseases.
-
Recently, a large number of domestic and foreign pharmaceutical companies have chosen to jointly develop new drugs
Time of Update: 2022-10-31
js?cdnversion='+~(-new Date()/36e5)]; In order to accelerate innovation and commercialize products, strong alliances between pharmaceutical companies have become the norm in the industry in recent years.
js?cdnversion='+~(-new Date()/36e5)]; In order to accelerate innovation and commercialize products, strong alliances between pharmaceutical companies have become the norm in the industry in recent years.
-
Matrine 10%-98% Sophora sophora extract Xi'an Quercus Ping Biology welcome consultation
Time of Update: 2022-10-31
7 【Storage Method】:Sealed in a cool, dry place 【Packing】:Aluminum foil bag 1kg/bag, 25kg/barrel or according to customer requirements 【Shelf life】:24 months 【Place of shipment】:Xi'an 【Manufacturer】:Que 【Species】: Plant extract - Sophora sophora Matrine 10%-98% Sophora Extract Xi'an Quercus Biology Welcome to consult 【Product Name】:Sophora Flavescens Extract 【English Name】:Sophora Flavescens Extract [Active Ingredients]: Matrine [Other Ingredients]: Oxidized Matrine Sophora Total Sophora [Ingredient English]: Matrine 【Molecular Formula】:C15H24N2O 【Molecular Weight】:248.
-
The new version of the "Measures for the Administration of Drug Recalls" came into force on November 1
Time of Update: 2022-10-31
On October 26, the State Food and Drug Administration issued a newly revised "Measures for the Administration of Drug Recalls" (hereinafter referred to as the "Measures"), which will come into effect
-
Piperine 95% 98% 10% Black Piperine Extract Industry News
Time of Update: 2022-10-31
Piperine 95% 98% 10% black pepperine extract industry dynamics Xi'an Liping Biotechnology Co.
Piperine 95% 98% 10% black pepperine extract industry dynamics Xi'an Liping Biotechnology Co.
Piperine 95% 98% 10% black pepperine extract industry dynamics Xi'an Liping Biotechnology Co.
-
New HIV Drugs! Biktarvy ® real-world data: Safe & effective in people with HIV with various comorbidities!
Time of Update: 2022-10-31
October 25, 2022 /BioValleyBIOON/ --Gilead Sciences recently announced the three-in-one compound drug Biktarvy (Chinese trade name: Bitovir, generic name: Biktigravir tablets, bictegravir ® 50mg/emtricitabine 200mg/tenofovir propofovir 25mg, BIC/FTC/ TAF) Real World Data (RWD) from the BICSTaR study: Confirm that Biktarvy is a universally well-tolerated and effective treatment regimen, regardless of prior treatment or comorbidity status in HIV-infected patients.
-
The demand for ophthalmic medical treatment continues to grow, and related companies are ushering in a favorable situation
Time of Update: 2022-10-31
In recent years, with the aging of China's population and the widespread use of electronic products, the incidence of eye diseases is continuing to increase, and the scale of the ophthalmic medical market has shown a steady growth trend.
-
Under the tide of "slimming" in the pharmaceutical industry, the medical equipment manufacturer will lay off nearly 4,000 employees
Time of Update: 2022-10-31
On October 24, Philips, a Dutch medical device manufacturer, announced urgent actions to improve performance, including immediate layoffs of about 4,000 employees worldwide and an expected charge of about 300 million euros in the coming quarters.
-
Policy interpretation of the Administrative Measures for Drug Recalls
Time of Update: 2022-10-31
Drug recall refers to the activity of the holder to withdraw drugs that have quality problems or other potential safety hazards on the market in accordance with the prescribed procedures, and take corresponding measures to control risks and eliminate hidden dangers in a timely manner.
-
New drug for Huntington's disease! Austedo (deuterated butbenazine) 3 years of long-term treatment data: effective, safe and well tolerated!
Time of Update: 2022-10-31
This is an approximately 3-year open-label, single-arm, 2-cohort, multicenter extension study that is evaluating the safety and tolerability of Austedo (Chinese trade name: Antetan, generic name: deutetrabenazine, deuterium butenazine tablets) in the long-term treatment of Huntington's disease (HD)-related chorea.
-
In order to enhance competitiveness, pharmaceutical machinery enterprises are accelerating the extension of the industrial chain layout
Time of Update: 2022-10-31
It is understood that in addition to the above-mentioned enterprises, since the beginning of this year, many pharmaceutical companies have also issued announcements such as acquisitions and cooperation, all of which are aimed at promoting the extended layout of the industrial chain and improving the productivity and market competitiveness of enterprises.
-
Dynamic analysis of Xi'an ferulic acid 98% fine powder rice bran extract supply industry
Time of Update: 2022-10-31
js?cdnversion='+~(-new Date()/36e5)]; Dynamic Analysis of Xi'an Ferulic Acid 98% Fine Powder Rice Bran Extract Supply Industry 1.
js?cdnversion='+~(-new Date()/36e5)]; Dynamic Analysis of Xi'an Ferulic Acid 98% Fine Powder Rice Bran Extract Supply Industry 1.
